BackPortage Biotech Overview

Portage Biotech Total Current Liabilities

Track Portage Biotech's total current liabilities ($1.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.10M
61.79% YoYΔ $-1.78M vs prior year quarter

Peer average

Loading

Portage Biotech Total Current Liabilities History

Loading

Portage Biotech vs. peers: Total Current Liabilities Comparison

Loading

Portage Biotech Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Portage Biotech (PRTG) FAQ

As of the most recent data (March 2025), PRTG shows a total current liabilities of $1.1M. That compares with $2.9M in the prior-year period — down 61.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PRTG's total current liabilities is now $1.1M (was $2.9M) — a 61.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Portage Biotech is outperforming or lagging.

Tracking PRTG's total current liabilities over time shows whether Portage Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $2.9M in the prior-year period — down 61.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Portage Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.1M) with ownership activity and broader fundamentals.

Portage Biotech's total current liabilities is $1.1M; compare it with other Energy names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.